Terms: = Liver cancer AND CgA AND Treatment
60 results:
1. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
[TBL] [Abstract] [Full Text] [Related]
4. Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation.
Wang Y; Wei X; Ke B; Liu J; Guo Y; Liu Y; Chen Y; Ding T; Wang Y; Meng B; Sun B; Zang F
Histopathology; 2023 Oct; 83(4):631-646. PubMed ID: 37356975
[TBL] [Abstract] [Full Text] [Related]
5. Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy.
Qiu M; Wang J; Bai J; Li X; Tian C; Liu Z; Zheng C; Clark AR; Cheng X; Liao X; Wu S; Lee RJ; Zhou X
Mol Pharm; 2023 Apr; 20(4):1951-1963. PubMed ID: 36952242
[TBL] [Abstract] [Full Text] [Related]
6. Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma.
Chen L; Hong W; Duan S; Li Y; Wang J; Zhu J
Cancer Biol Ther; 2022 Dec; 23(1):281-293. PubMed ID: 35323086
[TBL] [Abstract] [Full Text] [Related]
7. Clinical characteristics and prognostic model for extensive-stage small cell lung cancer: A retrospective study over an 8-year period.
Ni J; Zhang X; Wang H; Si X; Xu Y; Zhao J; Chen M; Zhang L; Wang M
Thorac Cancer; 2022 Feb; 13(4):539-548. PubMed ID: 34970848
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic stratification for patients with neuroendocrine tumours receiving 177Lu-Dotatate.
Chen L; Gnanasegaran G; Mandair D; Toumpanakis C; Caplin M; Navalkissoor S
Endocr Relat Cancer; 2022 Jan; 29(2):111-120. PubMed ID: 34932018
[TBL] [Abstract] [Full Text] [Related]
9. The role of grip strength and short physical performance battery test in predicting chemotherapy-related outcomes in older adults with cancer.
Almugbel FA; Timilshina N; Papadopoulos E; Al-Showbaki L; Alibhai SMH
J Geriatr Oncol; 2022 Apr; 13(3):318-324. PubMed ID: 34924306
[TBL] [Abstract] [Full Text] [Related]
10. Decaffeination and Neuraminidase Inhibitory Activity of Arabica Green Coffee (
Muchtaridi M; Lestari D; Khairul Ikram NK; Gazzali AM; Hariono M; Wahab HA
Molecules; 2021 Jun; 26(11):. PubMed ID: 34199752
[TBL] [Abstract] [Full Text] [Related]
11. Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.
Yang X; Feng Y; Liu Y; Ye X; Ji X; Sun L; Gao F; Zhang Q; Li Y; Zhu B; Wang X
Phytomedicine; 2021 Jul; 87():153575. PubMed ID: 33984593
[TBL] [Abstract] [Full Text] [Related]
12. Chlorogenic acid inhibits proliferation in human hepatoma cells by suppressing noncanonical NF-κB signaling pathway and triggering mitochondrial apoptosis.
Jiang Y; Nan H; Shi N; Hao W; Dong J; Chen H
Mol Biol Rep; 2021 Mar; 48(3):2351-2364. PubMed ID: 33738723
[TBL] [Abstract] [Full Text] [Related]
13. Charlson comorbidity index and G8 in older old adult(≥80 years) hepatocellular carcinoma patients treated with stereotactic body radiotherapy.
Loi M; Comito T; Franzese C; Desideri I; Dominici L; Lo Faro L; Clerici E; Franceschini D; Baldaccini D; Badalamenti M; Reggiori G; Lobefalo F; Scorsetti M
J Geriatr Oncol; 2021 Sep; 12(7):1100-1103. PubMed ID: 33461945
[TBL] [Abstract] [Full Text] [Related]
14. Role of the vulnerable elders survey-13 screening tool in predicting treatment plan modification for older adults with cancer.
Almugbel FA; Timilshina N; AlQurini N; Loucks A; Jin R; Berger A; Romanovsky L; Puts M; Alibhai SMH
J Geriatr Oncol; 2021 Jun; 12(5):786-792. PubMed ID: 33342723
[TBL] [Abstract] [Full Text] [Related]
15. Chromogranin A assessment in patients with neuroendocrine neoplasm of the small bowel and carcinoid syndrome treated with somatostatin analogues.
Gut P; Czarnywojtek A; Ruchała M
Adv Clin Exp Med; 2020 Nov; 29(11):1319-1324. PubMed ID: 33269818
[TBL] [Abstract] [Full Text] [Related]
16. The combination of coffee compounds attenuates early fibrosis-associated hepatocarcinogenesis in mice: involvement of miRNA profile modulation.
Romualdo GR; Prata GB; da Silva TC; Evangelista AF; Reis RM; Vinken M; Moreno FS; Cogliati B; Barbisan LF
J Nutr Biochem; 2020 Nov; 85():108479. PubMed ID: 32795656
[TBL] [Abstract] [Full Text] [Related]
17. Blood Molecular Genomic Analysis Predicts the Disease Course of Gastroenteropancreatic Neuroendocrine Tumor Patients: A Validation Study of the Predictive Value of the NETest®.
van Treijen MJC; van der Zee D; Heeres BC; Staal FCR; Vriens MR; Saveur LJ; Verbeek WHM; Korse CM; Maas M; Valk GD; Tesselaar MET
Neuroendocrinology; 2021; 111(6):586-598. PubMed ID: 32492680
[TBL] [Abstract] [Full Text] [Related]
18. Aberrant β-catenin Activity in Hepatoid Adenocarcinoma of the Stomach.
Wang N; Kong R; Han W; Lu J
Curr Mol Med; 2021; 21(8):655-664. PubMed ID: 32442081
[TBL] [Abstract] [Full Text] [Related]
19. Primary hepatic neuroendocrine tumors: A case report.
Hu HX; Yu T
Medicine (Baltimore); 2019 Dec; 98(50):e18278. PubMed ID: 31852101
[TBL] [Abstract] [Full Text] [Related]
20. Response Prediction of
Rathke H; Holland-Letz T; Mier W; Flechsig P; Mavriopoulou E; Röhrich M; Kopka K; Hohenfellner M; Giesel FL; Haberkorn U; Kratochwil C
J Nucl Med; 2020 May; 61(5):689-695. PubMed ID: 31653712
[TBL] [Abstract] [Full Text] [Related]
[Next]
